Alzamend Neuro Inc.
13F holders, Q3 2024 (September 30)12holders +10
2new positions
0sold out
$1.69avg. 13F price*
At the end of Q3 2024, 12 institutions reported holding Alzamend Neuro Inc. in their 13F filings, up 10 from Q2 2024. 2 opened new positions and 0 sold out. The largest holders were Susquehanna International Group, LLP ($28K), Truist Financial Corp. ($26K) and Tower Research Capital LLC (TRC) ($7K).
- Company
- Alzamend Neuro Inc.
- CUSIP
- 02262M506
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $30K |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 21,346 shares bought and 210 shares sold, net +21,135 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Susquehanna International Group, LLP | 0.00% | New | 16,601 | $28K |
| Truist Financial Corp. | 0.00% | No change | 15,498 | $26K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +704.8% | 4,167 | $7K |
| BlackRock, Inc. | 0.00% | — | 3,973 | $7K |
| Wells Fargo & Company | 0.00% | New | 1,000 | $2K |
| CoreCap Advisors, LLC | 0.00% | No change | 708 | $1K |
| Bank of America Corp. | 0.00% | Add +1005.3% | 105 | $177 |
| Harbor Investment Advisory, LLC | 0.00% | Reduce -90.0% | 20 | $34 |
| Activest Wealth Management | 0.00% | No change | 20 | $34 |
| City State Bank | 0.00% | No change | 4 | $7 |
| Morgan Stanley | 0.00% | Reduce -9.1% | 3 | $5 |
| Parallel Advisors, LLC | 0.00% | Reduce -90.9% | 3 | $5 |
"% of holder's portfolio" is ALZAMEND NEURO INC's weight in each manager's 13F, not the share of Alzamend Neuro Inc. the manager owns.